Cargando…
Sustained Treatment Response after Intravenous Cyclophosphamide in a Patient with Therapy-Resistant COVID-19 Acute Respiratory Distress Syndrome: A Case Report
Treatment of acute respiratory distress syndrome (ARDS) represents a severe complication of coronavirus disease 2019 (COVID-19) infection and is often challenging in intensive care treatment. Potential positive effects of intravenous cyclophosphamide have been reported in interstitial lung diseases...
Autores principales: | Haselwanter, Patrick, Bal, Christina, Gompelmann, Daniela, Idzko, Marco, Prosch, Helmut, Zauner, Christian, Schneeweiss-Gleixner, Mathias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488024/ https://www.ncbi.nlm.nih.gov/pubmed/37685571 http://dx.doi.org/10.3390/jcm12175506 |
Ejemplares similares
-
Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19
por: Lehmann, Antje, et al.
Publicado: (2022) -
Angioedema as a predominant symptom of Bordetella pertussis infection
por: Bal, Christina, et al.
Publicado: (2021) -
Impact of persistent D-dimer elevation following recovery from COVID-19
por: Lehmann, Antje, et al.
Publicado: (2021) -
Segmental endobronchial valve therapy for a vasculitis-induced emphysema
por: Bal, Christina, et al.
Publicado: (2022) -
Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019
por: Hermann, Martina, et al.
Publicado: (2022)